Related Experiment Video
Updated: Jun 30, 2026
Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
Published on: October 12, 2014
Primary Graft Dysfunction after Heart Transplantation: Current Evidence and Implications for Clinical Practice
Elena I Gavrila1, Jonathan S Dowell1, Ananya Gorrai1
1University of Texas Southwestern Medical Center, Dallas, TX, USA.
Insights
Primary graft dysfunction (PGD) complicates heart transplants, leading to high mortality. Understanding donor, recipient, and perioperative factors, alongside novel preservation methods, is crucial for mitigating PGD risk.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Primary graft dysfunction (PGD) is a severe complication following heart transplantation.
- It significantly impacts patient survival, with nearly 40% mortality within one year in its most severe form.
Purpose of the Study:
- To review the current literature on PGD.
- To highlight its definition, epidemiology, and risk factors in the current era of heart transplantation.
Main Methods:
- Literature review of primary graft dysfunction.
- Analysis of donor, recipient, and perioperative risk factors.
- Evaluation of organ preservation techniques and emerging biomarkers.
Main Results:
- PGD affects 8% of heart transplants, carrying a substantial mortality risk.
- PGD is multifactorial, influenced by donor/recipient factors and organ management.
- Biomarkers and advanced preservation methods like hypothermic oxygenation show promise in reducing PGD.
Conclusions:
- PGD remains a complex and poorly understood complication of heart transplantation.
- Further mechanistic studies are essential to elucidate PGD pathophysiology.
- Targeted interventions are needed for prophylaxis and treatment of PGD.
Purpose Of Review:
This review summarizes the current literature on primary graft dysfunction highlighting the current definition, reviewing epidemiology, and describing donor, recipient, and perioperative risk factors in the contemporary era.
Recent Findings:
PGD, in its most severe form, complicates 8% of heart transplants and portends a 1-year mortality of close to 40%. PGD is multifactorial and heterogeneous with contributions from donor and recipient risk as well as organ recovery and preservation modalities. Biomarkers may enhance risk stratification and lend insight into the underlying mechanism of PGD. Temperature-controlled storage and hypothermic oxygenation perfusion systems, in particular, may have significant potential to mitigate PGD risk. PGD is a devastating early complication of heart transplantation that is both complex and multifactorial. Despite its incidence and impact the underlying biology of PGD remains poorly understood. Future studies mechanistic studies are needed to address the underlying pathophysiology of PGD to develop targeted prophylactic and/or therapeutic interventions.
